121 related articles for article (PubMed ID: 10753725)
21. Expression and purification of a single-chain variable fragment antibody derived from a polyol-responsive monoclonal antibody.
Lamberski JA; Thompson NE; Burgess RR
Protein Expr Purif; 2006 May; 47(1):82-92. PubMed ID: 16216525
[TBL] [Abstract][Full Text] [Related]
22. Near-Atomic Resolution Structure of a Highly Neutralizing Fab Bound to Canine Parvovirus.
Organtini LJ; Lee H; Iketani S; Huang K; Ashley RE; Makhov AM; Conway JF; Parrish CR; Hafenstein S
J Virol; 2016 Nov; 90(21):9733-9742. PubMed ID: 27535057
[TBL] [Abstract][Full Text] [Related]
23. Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.
Nelson CD; Palermo LM; Hafenstein SL; Parrish CR
Virology; 2007 May; 361(2):283-93. PubMed ID: 17217977
[TBL] [Abstract][Full Text] [Related]
24. Immunodetection of Canine Parvovirus (CPV) in clinical samples by polyclonal antisera against CPV-VP2 protein expressed in Esherichia coli as an antigen.
Park JS; Choi BK; Vijayachandran LS; Ayyappan V; Chong CK; Lee KS; Kim SC; Choi CW
J Virol Methods; 2007 Dec; 146(1-2):281-7. PubMed ID: 17825928
[TBL] [Abstract][Full Text] [Related]
25. Nonstructural protein-2 and the replication of canine parvovirus.
Wang D; Yuan W; Davis I; Parrish CR
Virology; 1998 Jan; 240(2):273-81. PubMed ID: 9454701
[TBL] [Abstract][Full Text] [Related]
26. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
27. The primary structure and specificity determining residues displayed by recombinant salmon antibody domains.
Solem ST; Brandsdal BO; Smalås A; Jørgensen TØ
Mol Immunol; 2004 Apr; 40(18):1347-60. PubMed ID: 15072853
[TBL] [Abstract][Full Text] [Related]
28. Cloning and expression of a single-chain antibody fragment specific for foot-and-mouth disease virus.
Mason P; Berinstein A; Baxt B; Parsells R; Kang A; Rieder E
Virology; 1996 Oct; 224(2):548-54. PubMed ID: 8874516
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Cryptosporidium parvum infection of a mammalian cell culture by recombinant scFv antibodies.
Pokorny NJ; Boulter-Bitzer JI; Hall JC; Trevors JT; Lee H
Antonie Van Leeuwenhoek; 2008 Oct; 94(3):353-64. PubMed ID: 18581250
[TBL] [Abstract][Full Text] [Related]
30. [Construction of combinatorial immune library of single chain human antibodies to orthopoxviruses and selection from this library antibodies to recombinant protein prA30L of variola virus].
Dubrovskaia VV; Ulitin AB; Laman AG; Gileva IP; Bormotov NI; Il'ichev AA; Brovko FA; Shchelkunov SN; Belanov EF; Tikunova NV
Mol Biol (Mosk); 2007; 41(1):173-85. PubMed ID: 17380904
[TBL] [Abstract][Full Text] [Related]
31. Short synthetic CDR-peptides forming the antibody combining site of the monoclonal antibody against RNA bacteriophage fr neutralize the phage activity.
Steinbergs J; Kilchewska K; Lazdina U; Dishlers A; Ose V; Sällberg M; Tsimanis A
Hum Antibodies Hybridomas; 1996; 7(3):106-12. PubMed ID: 9057058
[TBL] [Abstract][Full Text] [Related]
32. Minor displacements in the insertion site provoke major differences in the induction of antibody responses by chimeric parvovirus-like particles.
Rueda P; Hurtado A; del Barrio M; Martínez-Torrecuadrada JL; Kamstrup S; Leclerc C; Casal JI
Virology; 1999 Oct; 263(1):89-99. PubMed ID: 10544085
[TBL] [Abstract][Full Text] [Related]
33. In silico analysis of the structure of variable domains of mouse single-chain antibodies specific to the human recombinant interferon beta1b.
Flyak AI; Pavlova MV; Gilchuk PV
Tsitol Genet; 2009; 43(1):54-60. PubMed ID: 19663316
[TBL] [Abstract][Full Text] [Related]
34. Cloning, expression, and characterization of single-chain variable fragment antibody against mycotoxin deoxynivalenol in recombinant Escherichia coli.
Choi GH; Lee DH; Min WK; Cho YJ; Kweon DH; Son DH; Park K; Seo JH
Protein Expr Purif; 2004 May; 35(1):84-92. PubMed ID: 15039070
[TBL] [Abstract][Full Text] [Related]
35. Antigenic and genetic analysis of canine parvoviruses in southern Africa.
Steinel A; Venter EH; Van Vuuren M; Parrish CR; Truyen U
Onderstepoort J Vet Res; 1998 Dec; 65(4):239-42. PubMed ID: 10192835
[TBL] [Abstract][Full Text] [Related]
36. Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21-47) fragment of HBsAg.
Yang X; Hu W; Li F; Xia H; Zhang Z
Protein Expr Purif; 2005 Jun; 41(2):341-8. PubMed ID: 15866720
[TBL] [Abstract][Full Text] [Related]
37. A humanized anti-M2 scFv shows protective in vitro activity against influenza.
Gabbard J; Velappan N; Di Niro R; Schmidt J; Jones CA; Tompkins SM; Bradbury AR
Protein Eng Des Sel; 2009 Mar; 22(3):189-98. PubMed ID: 19054791
[TBL] [Abstract][Full Text] [Related]
38. A single point mutation in framework region 3 of heavy chain affects viral neutralization dynamics of single-chain Fv against bovine herpes virus type 1.
Koti M; Nagy E; Kaushik AK
Vaccine; 2011 Oct; 29(45):7905-12. PubMed ID: 21872632
[TBL] [Abstract][Full Text] [Related]
39. Canine parvovirus infection: which diagnostic test for virus?
Desario C; Decaro N; Campolo M; Cavalli A; Cirone F; Elia G; Martella V; Lorusso E; Camero M; Buonavoglia C
J Virol Methods; 2005 Jun; 126(1-2):179-85. PubMed ID: 15847935
[TBL] [Abstract][Full Text] [Related]
40. Two influenza A virus-specific Fabs neutralize by inhibiting virus attachment to target cells, while neutralization by their IgGs is complex and occurs simultaneously through fusion inhibition and attachment inhibition.
Edwards MJ; Dimmock NJ
Virology; 2000 Dec; 278(2):423-35. PubMed ID: 11118365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
